Immunoparesis in Newly Diagnosed Multiple Myeloma and Its Impact on Clinical Outcome: A Real-World Experience

被引：0
|
作者：
Mahapatra, Manoranjan [1 ]
Verghese, Renjith Mathew [2 ]
Dhawan, Rishi [1 ]
Das, Jasmita [1 ]
Aggarwal, Mukul [1 ]
Kumar, Pradeep [1 ]
Kumar, Ganesh [1 ]
Seth, Tulika [1 ]
机构：
[1] AIIMS, New Delhi, India
[2] AFMC, Pune, Maharashtra, India
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
MM; immunoparesis; multiple myeloma; infection;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MM-681
引用
收藏
页码：S579 / S579
页数：1
相关论文
共 50 条
  • [1] The optimal dose of thalidomide on the treatment of newly diagnosed multiple myeloma: real-world experience in Taiwan
    Liao, Po Wei
    Teng, Chieh-Lin Jerry
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 : S159 - S159
  • [2] The Impact Of Immunoparesis On Outcomes Of Patients With Newly Diagnosed Multiple Myeloma: A Systematic Review
    Siwakoti, Ashmita
    Khadka, Sukhdev
    Grimshaw, Alyssa
    Giri, Smith
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB78 - AB78
  • [3] Impact of Etiological Cytogenetic Abnormalities on the Depth of Immunoparesis and Survival in Newly Diagnosed Multiple Myeloma
    Caro, Jessica
    Cairns, David
    Menzies, Tom
    Boyle, Eileen
    Pawlyn, Charlotte
    Cook, Gordon
    Kaiser, Martin
    Walker, Brian A.
    Owen, Roger
    Jackson, Graham H.
    Morgan, Gareth J.
    Heaney, Jennifer
    Drayson, Mark
    Davies, Faith E.
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2022, 22 (04): : E279 - E284
  • [4] IMPACT OF RENAL IMPAIRMENT IN NEWLY DIAGNOSED MULTIPLE MYELOMA IN A REAL WORLD SETTING
    Bove, V.
    Villano, F.
    Diaz, L.
    Riva, E.
    HAEMATOLOGICA, 2017, 102 : 776 - 776
  • [5] Real-world treatment patterns for patients with newly diagnosed multiple myeloma in Alberta, Canada
    Jimenez-Zepeda, Victor H.
    Chen, Guanmin
    Shaw, Eileen
    Farris, Megan S.
    Cowling, Tara
    Tay, Jason
    LEUKEMIA & LYMPHOMA, 2022, 63 (11) : 2557 - 2564
  • [6] The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials
    Fiala, Mark
    Dukeman, James
    Stockerl-Goldstein, Keith
    Tomasson, Michael
    Wildes, Tanya
    Vij, Ravi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2017, 17 (01): : E55 - E56
  • [7] The Real-World Characteristics and Outcomes of Newly Diagnosed Myeloma Patients Ineligible for Clinical Trials
    Fiala, Mark A.
    Dukeman, James
    Stockerl-Goldstein, Keith
    Tomasson, Michael H.
    Wildes, Tanya M.
    Vij, Ravi
    BLOOD, 2016, 128 (22)
  • [8] ELDERLY PATIENTS WITH NEWLY DIAGNOSED MULTIPLE MYELOMA IN THE REAL WORLD
    Yamazaki, E.
    Takahashi, H.
    Ishibashi, D.
    Kishimoto, K.
    Miyashita, K.
    Numata, A.
    Hattori, Y.
    Kawasaki, R.
    Koharazawa, H.
    Fujimaki, K.
    Taguchi, J.
    Fujita, H.
    Sakai, R.
    Fujisawa, S.
    Harano, H.
    Nakajima, H.
    HAEMATOLOGICA, 2017, 102 : 785 - 785
  • [9] Treatment of Newly Diagnosed Multiple Myeloma: A Real-world Study in A Western Single Center of China
    Liao, Yi
    Wang, Zhongwang
    Niu, Ting
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2019, 19 (10): : E230 - E230
  • [10] Ixazomib Based Maintenance Therapy for the Patients with Newly Diagnosed Multiple Myeloma in Real-World Practice
    Zhong, Liye
    Wei, Yongqiang
    Ping, Baohong
    Li, Xin
    Peng, Hongling
    Li, Yongqain
    Tian, Yuyang
    Liu, Zelin
    Luo, Jun
    Su, Yongzhong
    Chen, Haifei
    He, Yanjuan
    Li, Hongliang
    Wu, Congming
    Sun, Zhiqiang
    Shi, Keqian
    Li, Xiaoliang
    Zhang, Qing
    Hu, Guoyu
    Huang, Gang
    Huang, Zhenqian
    Wang, Weida
    Xia, Zhongjun
    BLOOD, 2021, 138
12345